Puey L. Chia
Melbourne, VIC, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Emerging bladder-sparing treatments for high risk non-muscle invasive bladder cancer.
Journal: Bladder cancer (Amsterdam, Netherlands)
Published: February 09, 2025
Tepotinib plus osimertinib in patients with EGFR-mutated non-small-cell lung cancer with MET amplification following progression on first-line osimertinib (INSIGHT 2): a multicentre, open-label, phase 2 trial.
Journal: The Lancet. Oncology
Published: January 19, 2024
Management of Oncogene Driven Locally Advanced Unresectable Non-small Cell Lung Cancer.
Journal: Expert review of anticancer therapy
Published: August 08, 2023
Editorial Comment to Impact of the coronavirus disease-2019 pandemic on the number of patients undergoing radical nephroureterectomy and postoperative adjuvant systematic therapy for upper tract urothelial carcinomas in Japan: A multicenter retrospective study.
Journal: International journal of urology : official journal of the Japanese Urological Association
Published: May 10, 2023
An approach to genetic testing in patients with metastatic castration-resistant prostate cancer in Singapore.
Journal: Annals of the Academy of Medicine, Singapore
Published: March 30, 2023
Resectable non-small cell lung cancer: an evolving landscape.
Journal: Translational lung cancer research
Published: July 13, 2022
Editorial Comment to Impact of neoadjuvant chemotherapy on survival and recurrence patterns after robot-assisted radical cystectomy for muscle-invasive bladder cancer: Results from the International Robotic Cystectomy Consortium.
Journal: International journal of urology : official journal of the Japanese Urological Association
Published: February 10, 2022
Lung Cancer in Singapore.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: November 18, 2020
Expression of EGFR and conformational forms of EGFR in malignant pleural mesothelioma and its impact on survival.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: October 04, 2020
Analysis of angiogenic and stromal biomarkers in a large malignant mesothelioma cohort.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: July 08, 2020
Epidermal growth factor receptor (EGFR)-targeted therapies in mesothelioma.
Journal: Expert opinion on drug delivery
Published: March 28, 2019
Last Updated: 09/26/2026